HHS Mandates Quarterly Medical Equipment Forecasts to Boost Domestic Production
Washington, Sunday, 20 September 2026.
To reduce relying on foreign suppliers for 90% of medical gear, the U.S. government now requires quarterly equipment demand forecasts, offering domestic manufacturers vital procurement predictability.
HHS Mandates Quarterly Medical Equipment Forecasts to Boost Domestic Production
The U.S. Department of Health and Human Services (HHS) has established a new policy requiring all its divisions to publish a quarterly personal protective equipment (PPE) demand forecast [1]. Announced on 20 September 2026, the move aims to provide domestic manufacturers with clear procurement visibility, mitigating supply chain vulnerabilities and reducing long-term reliance on foreign suppliers [1]. The American Medical Manufacturers Association (AMMA) has praised the initiative, noting that leadership focusing on purchasing forecasts helps American factories turn agendas into concrete procurement practices [1].
Supply Chain Vulnerabilities and Import Dependence
The United States currently imports 80% to 90% of its Personal Protective Equipment (PPE), creating significant economic exposure [1]. In 2024, over 87 percent of U.S. medical glove imports originated from just three countries, including China [1]. This concentration of supply sources highlights the fragility of the current medical supply chain, prompting federal initiatives such as Section 232 investigations into PPE imports and new Buy American legislation [1]. Predictability from public and private industry is what turns capacity into hired workers, new equipment, and lines that run every day [1].
Domestic Capacity and Scaling Potential
AMMA members currently possess the capacity to produce approximately 4.8 billion nitrile examination gloves annually, representing 8 percent of the estimated 60 billion-glove hospital market [1]. However, these manufacturers have the capability to scale production to between 28 and 34 billion units [1]. The potential increase in production capacity is significant, calculated as 23.2 billion units at the lower end of the scaling range [1]. Additionally, members have an annual production capacity of 2.1 billion surgical masks, which is 30 percent of hospital demand, scalable to greater than 5.1 billion [1].
Economic Implications and Future Outlook
Giving domestic PPE producers greater visibility into future federal demand means greater certainty to invest, hire, and build capacity here at home [2]. The AMMA is now urging the VA and GSA to adopt similar forecasting practices and requiring private health systems to publish comparable forecasts [1]. If HHS can tell manufacturers what it will need, the systems and Group Purchasing Organizations that buy the other 90 percent can do the same [1]. Manufacturers are starting to believe the market they have been asked to build is actually coming [1].